Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03590236
Other study ID # DF0069UG
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date August 20, 2017
Est. completion date August 10, 2018

Study information

Verified date July 2018
Source Universidad de Granada
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic pelvic pain (CPP) is considered as nonmalignant recurrent or continuous pain related to the structures of the pelvis. The objective of this study was to evaluate the effects of graded exposure therapy in women with chronic pelvic pain.


Description:

Chronic pelvic pain (CPP) is considered as nonmalignant recurrent or continuous pain related to the structures of the pelvis. This condition lasts at least 6 months, and many times is associated with negative cognitive, emotional, sexual and behavioral consequences.In addition to the high economic cost, CPP is also costly in emotional and psychological suffering. This clinical trial aims to evaluate the effects of a program based on graded exposure therapy in women with chronic pelvic pain.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 60
Est. completion date August 10, 2018
Est. primary completion date February 12, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Diagnosis of chronic pelvic pain

- Moderate fear of movement

Exclusion Criteria:

- Other clinical diagnosis.

- Men

- Other pathology such as neurological disease.

- Cognitive impairment.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Graded exposure therapy
Patients included in this group received graded exposure therapy consisting on counselling, a graded activity through postural exercises and individual training focused on 5 activities selected by the patients. The treatment will include 5 sessions added to the 12 sessions of physiotherapy.
Physiotherapy
Physiotherapy intervention will include soft tissue mobilizations and myofascial release combined with deep-pressure massage to decrease trigger point-related pain and tension. In addition joint mobilization and muscle energy techniques will be included.

Locations

Country Name City State
Spain Department of Physical Therapy Granada

Sponsors (1)

Lead Sponsor Collaborator
Universidad de Granada

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fear-avoidance behaviors Changes from baseline to the end of the intervention will be assessed with the Fear Avoidance Beliefs Questionnaire (FABQ) using the physical activity subscale. This subscale focus on patients' beliefs about how physical activity affected their pain. The values ranges from 0 to 24 with higher scores indicating higher levels of fear-avoidance beliefs. Baseline, 6 weeks
Secondary Pain assessed by the Brief Pain Inventory Changes from baseline to the end of the intervention on pain will be assessed using the Brief Pain Inventory. This instrument evaluates the intensity of pain and also the degree to which the pain interferes in activities of daily living. The arithmetic mean ranging from 0 to 10 of the four severity items will be used as measures of pain severity; the arithmetic mean ranging from 0 to 10 of the seven interference items will be used as a measure of pain interference. Higher score represents worse pain. Baseline, 6 weeks
Secondary Disability Changes from baseline to the end of the intervention will ibe assessed using the Oswestry Disability Index. It includes 10 items that assess how pain affects common daily activities. Scores range from 0 (no disability) to 100 (completely disabled), so higher scores indicate higher disability. Baseline, 6 weeks
Secondary Activity performance The perceived quality of performance will be assessed using the Canadian Ocuppational Performance Measure Baseline, 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT03638856 - Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy N/A
Withdrawn NCT03272360 - Endometriosis Biomarker Discovery Study N/A
Completed NCT01020162 - Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain N/A
Recruiting NCT05836454 - The Soft Tissue Mobilization Techniques on PMS N/A
Completed NCT02372903 - Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Endometriosis N/A
Recruiting NCT05185180 - Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
Recruiting NCT05970783 - A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease Phase 3
Completed NCT04615247 - Program to Overcome Pelvic Pain Study N/A
Completed NCT02721108 - Mindfulness Meditation for Chronic Pelvic Pain Management N/A
Not yet recruiting NCT00844012 - Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain Phase 4
Recruiting NCT04976751 - Real World Study on the Application of Appropriate Electrophysiological Technology in the Diagnosis and Treatment of Andrology Diseases in Northwest China Phase 1
Withdrawn NCT04252040 - Open Label Extension Study of tDCS Plus Guided Imagery for Women With Chronic Pelvic Pain (CPP) N/A
Completed NCT01802528 - Clinical Effectiveness of Obturator Externus Muscle Injection in Chronic Pelvic Pain Patients N/A
Completed NCT03175809 - Pelvic Floor Muscles Training Associated Dry Needling for Chronic Pelvic Pain N/A
Recruiting NCT05324280 - Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain N/A
Not yet recruiting NCT02556411 - Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS) N/A
Completed NCT04104542 - MOCHI: An RCT of Mindfulness as Treatment for Chronic Pelvic Pain in AD Women N/A
Completed NCT01553201 - Botulinum Toxin for Pelvic Pain in Women With Endometriosis Phase 1/Phase 2
Completed NCT03617627 - Self-management Program in Chronic Pelvic Pain N/A
Recruiting NCT06019091 - Optimal Frequency Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Pelvic Pain in Adults N/A